U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020839

Expand all

PLAVIX (CLOPIDOGREL BISULFATE)
EQ 75MG BASE
Marketing Status: Prescription
Active Ingredient: CLOPIDOGREL BISULFATE
Proprietary Name: PLAVIX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020839
Product Number: 001
Approval Date: Nov 17, 1997
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
PLAVIX (CLOPIDOGREL BISULFATE)
EQ 300MG BASE
Marketing Status: Prescription
Active Ingredient: CLOPIDOGREL BISULFATE
Proprietary Name: PLAVIX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020839
Product Number: 002
Approval Date: Sep 20, 2007
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top